GlassScriptPhysician profile
David A Santos
NPI 1326360280
$4,383.40
in general payments reported to CMS, 2019-2025
9 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,825 · 2020: $349 · 2021: $292 · 2022: $384 · 2023: $88.41 · 2024: $250 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507 · Education: $25.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.09 |
| Education | $25.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,978.08 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $1,549.94 | 2019-2022 | |
| Guard Medical INC. | $326.33 | 2024-2025 | Npseal Large, Npseal |
| Allergan, INC. | $271.73 | 2021-2022 | |
| Covidien LP | $143.22 | 2019 | |
| Distalmotion US | $44.84 | 2025 | Dexter L6 Robot |
| W. L. Gore & Associates, INC. | $25.89 | 2023 | Gore Bio-A Tissue Reinforcement |
| Becton, Dickinson and Company | $24.30 | 2023 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $19.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Santos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.